LYEL

$0.00

(

+0.00%

)
Quote details

stock

Lyell Immunopharma Inc

NASDAQ | LYEL

34.83

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 12, 2025)

$709.76M

Market Cap

-

P/E Ratio

-22.75

EPS

$34.43

52 Week High

$7.65

52 Week Low

HEALTHCARE

Sector

LYEL Chart

Recent Chart
Price Action

LYEL Technicals

Tags:

LYEL Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $61K
Total Revenue $61K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$359M
Selling General And Administrative $52M
Research And Development $172M
Operating Expenses $359M
Investment Income Net -
Net Interest Income $24M
Interest Income $24M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $20M
Income Before Tax -$343M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$343M
Comprehensive Income Net Of Tax -
Ebit -$220M
Ebitda -$201M
Net Income -$343M

Revenue & Profitability

LYEL Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $491M
Total Current Assets $380M
Cash And Cash Equivalents At Carrying Value $106M
Cash And Short Term Investments $106M
Inventory -
Current Net Receivables -
Total Non Current Assets $111M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $32M
Short Term Investments $265M
Other Current Assets $9.1M
Other Non Current Assets -
Total Liabilities $108M
Total Current Liabilities $54M
Current Accounts Payable $5.4M
Deferred Revenue -
Current Debt -
Short Term Debt $8M
Total Non Current Liabilities $54M
Capital Lease Obligations $59M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $59M
Other Current Liabilities $40M
Other Non Current Liabilities $3.3M
Total Shareholder Equity $383M
Treasury Stock -
Retained Earnings -$1.3B
Common Stock $29K
Common Stock Shares Outstanding $13M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $61K
Total Revenue $61K
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$359M
Selling General And Administrative $52M
Research And Development $172M
Operating Expenses $359M
Investment Income Net -
Net Interest Income $24M
Interest Income $24M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $20M
Income Before Tax -$343M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$343M
Comprehensive Income Net Of Tax -
Ebit -$220M
Ebitda -$201M
Net Income -$343M

LYEL News

LYEL Profile

Lyell Immunopharma Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Lyell Immunopharma, Inc. is a cutting-edge biopharmaceutical company headquartered in South San Francisco, California, with additional facilities in Seattle and Bothell, Washington. The company specializes in pioneering T-cell reprogramming technologies designed to formulate innovative therapies targeting solid tumors, thereby enhancing the effectiveness and longevity of T-cell treatments. With its proprietary platforms and a strong commitment to meeting significant unmet medical needs in oncology, Lyell is well-positioned to transform cancer treatment and play a critical role in the evolving immuno-oncology sector.

LPTX
+368.57%
$2.05
PAVS
+21.15%
$0.04
YCBD
+102.85%
$1.28
YGMZ
-61.42%
$0.02
OCG
+261.14%
$3.29
NVDA
-2.13%
$177.07
CGC
+46.02%
$1.65
WOK
-28.86%
$0.11
RIVN
+16.21%
$19.09
PLUG
+2.75%
$2.42
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
ATPC
-25.66%
$0.13
TSLA
+1.72%
$454.61
TLRY
+35.47%
$11.42
KAVL
-16.35%
$0.16
AVGO
-10.83%
$362.33
TNYA
-33.66%
$0.90
FRMI
-32.49%
$10.29
ADAP
-15.14%
$0.05
ZDGE
+20.57%
$2.93
ASST
-2.40%
$0.89
AKAN
+19.31%
$0.93
SOND
-23.45%
$0.12
ONDS
+0.56%
$9.07
VIVK
+0.40%
$0.07
INTC
-2.61%
$38.47
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
TE
-9.62%
$5.30
APLT
-45.50%
$0.11
SOFI
+1.14%
$27.38
PLTD
+1.90%
$6.44
WULF
-6.79%
$14.75
DNN
-5.80%
$2.59
PLTR
-1.09%
$185.48
IRBT
-10.63%
$4.46
BMNR
-5.75%
$36.17
MTSR
-0.35%
$70.50
RR
-8.65%
$4.27
ASBP
-7.84%
$0.09
MARA
-2.01%
$11.60
FI
+2.38%
$68.16
NFLX
+1.34%
$95.35
F
+1.02%
$13.76
VALE
-4.55%
$12.68
AFMD
-34.94%
$0.18
AAL
+0.90%
$15.09
RZLT
+9.32%
$1.53
CRWV
-8.46%
$79.97
RKLB
+0.29%
$63.72
IVP
-6.77%
$0.04
BITF
-5.95%
$2.76
CLSK
-2.64%
$14.42
AMD
-3.52%
$213.63
TWOH
0.00%
$0.00
GOOGL
-0.85%
$309.75
HOOD
-2.10%
$120.78
GRYP
-10.38%
$1.38
SNAP
-1.89%
$7.49
CAN
-6.61%
$0.86
BBD
+1.31%
$3.45
MODV
-25.22%
$0.43
KPLT
+20.87%
$7.50
CIFR
-6.54%
$17.64
GRAB
+0.77%
$5.22
SOUN
-0.46%
$11.97
CHR
-0.48%
$0.04
AMZN
-1.66%
$226.45
NIO
0.00%
$5.13
BTG
-1.82%
$4.59
WBD
+1.30%
$29.87
QBTS
-5.71%
$26.38
PFE
+0.66%
$25.97
HL
-3.85%
$18.60
ABEV
+1.40%
$2.53
ACHR
-3.79%
$8.23
NXDR
-9.11%
$2.51
RIG
-1.75%
$4.20
AG
-6.39%
$15.73
IBRX
+11.41%
$2.44
MU
-4.88%
$245.82
BAC
+1.07%
$55.14
CDE
-2.64%
$17.01
BYND
-3.34%
$1.14
RGTI
-6.54%
$25.12
AAPL
+0.19%
$278.57
SHOT
-74.37%
$0.39
LULU
+10.12%
$205.93
APLD
-6.47%
$28.76
ZAPP
-46.30%
$0.15
BTBT
-7.47%
$2.27
BLNK
-9.93%
$0.79
T
+1.50%
$24.66
PCG
+3.10%
$15.29
NCPL
+25.49%
$1.33
CRCG
-13.05%
$2.93
ORCL
-3.57%
$191.74
LPTX
+368.57%
$2.05
PAVS
+21.15%
$0.04
YCBD
+102.85%
$1.28
YGMZ
-61.42%
$0.02
OCG
+261.14%
$3.29
NVDA
-2.13%
$177.07
CGC
+46.02%
$1.65
WOK
-28.86%
$0.11
RIVN
+16.21%
$19.09
PLUG
+2.75%
$2.42
KIND
+9.48%
$2.77
AXDX
-61.36%
$0.03
ATPC
-25.66%
$0.13
TSLA
+1.72%
$454.61
TLRY
+35.47%
$11.42
KAVL
-16.35%
$0.16
AVGO
-10.83%
$362.33
TNYA
-33.66%
$0.90
FRMI
-32.49%
$10.29
ADAP
-15.14%
$0.05
ZDGE
+20.57%
$2.93
ASST
-2.40%
$0.89
AKAN
+19.31%
$0.93
SOND
-23.45%
$0.12
ONDS
+0.56%
$9.07
VIVK
+0.40%
$0.07
INTC
-2.61%
$38.47
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SRM
+53.27%
$10.30
TE
-9.62%
$5.30
APLT
-45.50%
$0.11
SOFI
+1.14%
$27.38
PLTD
+1.90%
$6.44
WULF
-6.79%
$14.75
DNN
-5.80%
$2.59
PLTR
-1.09%
$185.48
IRBT
-10.63%
$4.46
BMNR
-5.75%
$36.17
MTSR
-0.35%
$70.50
RR
-8.65%
$4.27
ASBP
-7.84%
$0.09
MARA
-2.01%
$11.60
FI
+2.38%
$68.16
NFLX
+1.34%
$95.35
F
+1.02%
$13.76
VALE
-4.55%
$12.68
AFMD
-34.94%
$0.18
AAL
+0.90%
$15.09
RZLT
+9.32%
$1.53
CRWV
-8.46%
$79.97
RKLB
+0.29%
$63.72
IVP
-6.77%
$0.04
BITF
-5.95%
$2.76
CLSK
-2.64%
$14.42
AMD
-3.52%
$213.63
TWOH
0.00%
$0.00
GOOGL
-0.85%
$309.75
HOOD
-2.10%
$120.78
GRYP
-10.38%
$1.38
SNAP
-1.89%
$7.49
CAN
-6.61%
$0.86
BBD
+1.31%
$3.45
MODV
-25.22%
$0.43
KPLT
+20.87%
$7.50
CIFR
-6.54%
$17.64
GRAB
+0.77%
$5.22
SOUN
-0.46%
$11.97
CHR
-0.48%
$0.04
AMZN
-1.66%
$226.45
NIO
0.00%
$5.13
BTG
-1.82%
$4.59
WBD
+1.30%
$29.87
QBTS
-5.71%
$26.38
PFE
+0.66%
$25.97
HL
-3.85%
$18.60
ABEV
+1.40%
$2.53
ACHR
-3.79%
$8.23
NXDR
-9.11%
$2.51
RIG
-1.75%
$4.20
AG
-6.39%
$15.73
IBRX
+11.41%
$2.44
MU
-4.88%
$245.82
BAC
+1.07%
$55.14
CDE
-2.64%
$17.01
BYND
-3.34%
$1.14
RGTI
-6.54%
$25.12
AAPL
+0.19%
$278.57
SHOT
-74.37%
$0.39
LULU
+10.12%
$205.93
APLD
-6.47%
$28.76
ZAPP
-46.30%
$0.15
BTBT
-7.47%
$2.27
BLNK
-9.93%
$0.79
T
+1.50%
$24.66
PCG
+3.10%
$15.29
NCPL
+25.49%
$1.33
CRCG
-13.05%
$2.93
ORCL
-3.57%
$191.74

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.